Orthopedic Bone Cement And Casting Materials Global Market Report 2025

The orthopedic bone cement and casting materials market size has grown strongly in recent years. It will grow from $2.89 billion in 2024 to $3.06 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth during the historic period can be attributed to improvements in healthcare infrastructure, increased awareness of orthopedic treatment options, a rise in joint replacement surgeries, supportive government funding and reimbursement policies, and growing demand for non-invasive procedures.

The orthopedic bone cement and casting materials market size is expected to see strong growth in the next few years. It will grow to $3.86 billion in 2029 at a compound annual growth rate (CAGR) of 6%. The growth during the forecast period can be attributed to the rising geriatric population, an increase in bone fractures and injuries, greater adoption of minimally invasive surgeries, a higher prevalence of osteoporosis, and a surge in sports-related injuries. Key trends expected during this period include advancements in casting materials, enhanced surgical techniques, the emergence of bioactive bone cements, the introduction of patient-specific implants, and collaborations between orthopedic surgeons and material scientists.

The growing incidence of road accidents is expected to accelerate the growth of the orthopedic bone cement and casting materials market. The rise in road accidents can be attributed to factors such as distracted driving, which reduces drivers' focus and reaction times, thereby increasing the risk of accidents. These accidents often result in fractures and bone injuries that require surgical intervention and the use of materials such as bone cement for implant fixation and casting materials to immobilize fractures during the healing process. For example, in November 2024, the Department of Transportation, a U.S.-based government agency, reported that 42,514 lives were lost in road accidents across the U.S. in 2022, marking a 10% increase from 2021. As a result, the growing frequency of road accidents is expected to drive demand for orthopedic bone cement and casting materials.

Leading companies in the orthopedic bone cement and casting materials market are focusing on developing advanced products such as antibiotic bone cement to prevent post-surgical infections. Antibiotic bone cement, a PMMA-based material infused with antibiotics, is used during orthopedic procedures, particularly joint replacements, to prevent or treat infections. For example, in March 2025, Zimmer Biomet, a U.S.-based medical technology company, launched Tekcem 1G and Tekcem 3G antibiotic bone cements. These products stand out for their incorporation of gentamicin, an antibiotic that helps protect against infections during joint reconstruction and arthroplasty procedures, making them ideal for primary and revision surgeries following trauma. Additionally, their low monomer release reduces toxicity and shrinkage, further enhancing their appeal for orthopedic use.

In September 2024, Biocomposites, a UK-based medical device company, acquired shares in Laboratorios SL and Synergie Ingénierie Médicale for an undisclosed amount. This acquisition gives Biocomposites full control over the SYNICEM and Subiton product lines, supporting its goal of becoming a leader in the innovation of products designed for treating bone and soft tissue infections. Laboratorios SL is based in Spain, and Synergie Ingénierie Médicale is based in France, both specializing in the manufacturing of orthopedic bone cement.

Major players in the orthopedic bone cement and casting materials market are Johnson & Johnson Services Inc, 3M Health Care Ltd, Medtronic plc, Stryker Corporation, Biomet Inc, Zimmer Biomet Holdings Inc., Smith & Nephew Plc, Arthrex Inc., DJO Global Inc, Wright Medical Group N.V., Exactech inc, BSN Medical GmbH, DePuy Synthes Inc, Heraeus Medical GmbH, Aap Implantate AG, BioPoly LLC, Subiton Laboratorios S.A., Synimed Syringie Ingenierie Medicals, G21 S.r.l, Scanos.

North America was the largest region in the orthopedic bone cement and casting materials market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in orthopedic bone cement and casting materials report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the orthopedic bone cement and casting materials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Orthopedic bone cement and casting materials are specialized medical substances used in orthopedic surgeries to stabilize fractures, promote bone healing, and aid in implant fixation. Bone cement is primarily used to anchor prosthetic joints and fill bone defects, providing structural stability and enhancing recovery. Casting materials serve to immobilize fractures, maintain proper bone alignment, and limit movement to ensure effective healing.

The primary products in this category include bone cement and casting materials. Bone cement, commonly composed of polymethyl methacrylate (PMMA), is a biomaterial utilized to secure implants and fill bone voids during orthopedic procedures. These products are made from various materials such as PMMA, calcium phosphate, plaster of Paris, fiberglass, and others, and come in several forms, including injectable options, prepackaged formulations, and injectable bone substitutes. They are used in a range of applications such as joint arthroplasty, trauma cases, sports injuries, and spinal surgeries. End users include hospitals, ambulatory surgical centers, orthopedic clinics, and other healthcare facilities.

The orthopedic bone cement and casting materials market research report is one of a series of new reports that provides orthopedic bone cement and casting materials market statistics, including orthopedic bone cement and casting materials industry global market size, regional shares, competitors with a orthopedic bone cement and casting materials market share, detailed orthopedic bone cement and casting materials market segments, market trends and opportunities, and any further data you may need to thrive in the orthopedic bone cement and casting materials industry. This orthopedic bone cement and casting materials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The orthopedic bone cement and casting materials market consists of sales of bioresorbable bone cement, radiopaque bone cement, bone cement spacer and casting tapes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.